DarioHealth (NASDAQ:DRIO) issued its earnings results on Tuesday. The company reported ($0.13) earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of ($0.14) by $0.01, Morningstar.com reports. DarioHealth had a negative net margin of 257.11% and a negative return on equity of 296.31%. The firm had revenue of $1.65 million for the quarter.

Shares of DRIO traded down $0.14 during mid-day trading on Wednesday, reaching $0.42. 11,194 shares of the company’s stock traded hands, compared to its average volume of 90,891. The firm’s 50-day simple moving average is $0.49. The company has a current ratio of 1.41, a quick ratio of 1.13 and a debt-to-equity ratio of 0.14. DarioHealth has a 12 month low of $0.36 and a 12 month high of $1.38.

A hedge fund recently raised its stake in DarioHealth stock. BlackRock Inc. grew its holdings in shares of DarioHealth Corp (NASDAQ:DRIO) by 90.4% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 41,602 shares of the company’s stock after buying an additional 19,748 shares during the period. BlackRock Inc. owned 0.12% of DarioHealth worth $33,000 as of its most recent filing with the Securities and Exchange Commission. Hedge funds and other institutional investors own 18.92% of the company’s stock.

Separately, Craig Hallum began coverage on shares of DarioHealth in a report on Thursday, June 6th. They issued a “buy” rating and a $1.50 target price on the stock.

About DarioHealth

DarioHealth Corp., a digital health company, develops and commercializes patented and proprietary technologies providing consumers with laboratory-testing capabilities using smart phones and other mobile devices in the United States, Europe, Australia, and Canada. The company's flagship product, Dario, also known as Dario Smart Diabetes Management Solution, is a mobile, real-time, cloud-based, diabetes management solution based on a software application combined with Dario Smart Meter, a pocket-sized, blood glucose monitoring device.

Featured Story: How is diluted EPS different from basic EPS?

Earnings History for DarioHealth (NASDAQ:DRIO)

Receive News & Ratings for DarioHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DarioHealth and related companies with MarketBeat.com's FREE daily email newsletter.